tiprankstipranks
Wuxi Biologics (Cayman) Inc. (HK:2269)
:2269
Hong Kong Market
2269
Wuxi Biologics (Cayman)
RESEARCH TOOLSreports
Want to see HK:2269 full AI Analyst Report?

Wuxi Biologics (Cayman) (2269) Financial Statements

55 Followers

Wuxi Biologics (Cayman) Financial Overview

Wuxi Biologics (Cayman)'s market cap is currently HK$135.24B. The company's EPS TTM is HK$1.21; its P/E ratio is 11.12; Wuxi Biologics (Cayman) is scheduled to report earnings on March 24, 2026, and the estimated EPS forecast is HK$0.68. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 21.23B¥ 18.68B¥ 17.03B¥ 15.27B¥ 10.29B
Gross Profit¥ 9.76B¥ 7.65B¥ 6.83B¥ 6.72B¥ 4.83B
Operating Income¥ 6.47B¥ 4.97B¥ 4.45B¥ 4.34B¥ 3.19B
EBITDA¥ 8.17B¥ 6.43B¥ 5.50B¥ 6.22B¥ 4.51B
Net Income¥ 4.78B¥ 3.36B¥ 3.40B¥ 4.42B¥ 3.39B
Balance Sheet
Cash & Short-Term Investments¥ 15.74B¥ 10.71B¥ 11.24B¥ 8.71B¥ 11.13B
Total Assets¥ 63.72B¥ 56.98B¥ 56.58B¥ 49.56B¥ 44.03B
Total Debt¥ 3.11B¥ 4.94B¥ 4.56B¥ 4.42B¥ 4.30B
Net Debt¥ -6.12B¥ -3.34B¥ -5.11B¥ -1.97B¥ -4.71B
Total Liabilities¥ 10.66B¥ 11.50B¥ 12.56B¥ 13.35B¥ 11.33B
Stockholders' Equity¥ 47.27B¥ 41.82B¥ 40.33B¥ 35.05B¥ 32.28B
Cash Flow
Free Cash Flow¥ 2.80B¥ 1.29B¥ 437.20M¥ -326.72M¥ -3.09B
Operating Cash Flow¥ 6.39B¥ 5.22B¥ 4.67B¥ 5.54B¥ 3.43B
Investing Cash Flow¥ -3.38B¥ -3.94B¥ -3.23B¥ -5.91B¥ -9.60B
Financing Cash Flow¥ -1.95B¥ -2.75B¥ 1.96B¥ -2.59B¥ 8.21B
Currency in CNY

Wuxi Biologics (Cayman) Earnings and Revenue History

Income Statement >

Wuxi Biologics (Cayman) Debt to Assets

Balance Sheet >

Wuxi Biologics (Cayman) Cash Flow

Cash Flow >

Wuxi Biologics (Cayman) Forecast EPS vs Actual EPS

Earnings >